Naveen Pemmaraju: Co-chairing with Claire Harrison at iwMPN
Naveen Pemmaraju shared a post on X:
“International Workshop on Myelodysplastic Syndromes & Myeloproliferative Neoplasms (iwMPN) 2024 that I am co-chairing with Claire Harrison. Great talks in our new endpoints in Myeloproliferative Neoplasms (MPNs) session {Left is Novel slide proposing AUC depth and duration by J.Mascarhenas; Right is Ruben A. Mesa great talk about new approaches for thinking about MPN sxs in 2024 & beyond.”
Source: Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023